Pediatric ESAP Faculty

 
Dr. Craig Alter Craig A. Alter, MD, (chair) received his undergraduate degree in mathematics and chemistry at the University of Pennsylvania and then attended Harvard Medical School in a joint program with the Massachusetts Institute of Technology. He completed his residency at the Children’s Hospital Boston and then completed his pediatric endocrinology fellowship at the Children’s Hospital of Philadelphia (CHOP) where he was awarded the Fellow Teacher of the Year. He served as a clinical endocrinologist at the University of Massachusetts where he was director of the Children’s Diabetes Center. At the University of Massachusetts, he won the Faculty Teaching Award in 1996 before rejoining the Endocrinology Division at CHOP in 1999. Dr. Alter is the fellowship program director in the Division of Endocrinology and Diabetes at CHOP and is professor of clinical pediatrics. Dr. Alter is the recipient of the Dean's Award for Excellence in Teaching at the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania. Dr. Alter has lectured nationally on various topics in endocrinology. In addition, he enjoys studying methods of education and has taught and run workshops nationally on improving methods of teaching in medicine.

Dr. Rachel Gafni Rachel I. Gafni, MD, received her undergraduate degree from Barnard College of Columbia University and her medical degree from Temple University School of Medicine. She completed a pediatric residency at the Children’s Hospital of Philadelphia, followed by a pediatric endocrinology fellowship at the National Institutes of Health (NIH), serving as a commissioned officer in the Public Health Service from 1996 to 2002.  From 2002 to 2007, she served as an assistant professor at the University of Maryland, during which time she continued to work as a contractor for the National Cancer Institute, NIH. Dr. Gafni returned to the NIH full time in 2007 and is a staff clinician and clinical investigator in the Craniofacial and Skeletal Diseases Branch of the National Institute of Dental and Craniofacial Research, NIH. She also serves as faculty in the NIH Pediatric Endocrinology Training Program. She is an investigator on several protocols studying and treating patients with endocrine disorders including hypoparathyroidism, McCune-Albright syndrome, and other metabolic bone diseases. Her primary research interests include investigations into the molecular mechanisms, diagnosis, and treatment of calcium, phosphorus, and skeletal disorders. 

Dr. Stephen Huang Stephen A. Huang, MD, obtained his medical degree from the University of Pennsylvania School of Medicine. Following his residency training in pediatrics at Harvard Medical School, Dr. Huang completed pediatric endocrinology and thyroidology fellowships at Children’s Hospital Boston and the Brigham and Women’s Hospital, respectively. Dr. Huang is involved in both clinical practice and laboratory research, with a special emphasis on pediatric thyroidology. Dr. Huang serves as the director of the Thyroid Program at Children’s Hospital Boston and director of thyroid research in the hospital’s Division of Endocrinology. Dr. Huang’s research is in the field of thyroid hormone metabolism and relates to the modulation of local thyroid status during injury. Because of clinical interests in the long-term care of childhood thyroid cancer, he maintains active appointments in the Brigham and Women’s Hospital and the Dana Farber Cancer Institute.

Dr. Lorraine Katz Lorraine E. Levitt Katz, MD, graduated from Barnard College of Columbia University and the University of Connecticut School of Medicine. She completed her pediatrics residency at Babies Hospital/Columbia Presbyterian and a fellowship in pediatric endocrinology at the Children’s Hospital of Philadelphia (CHOP). Her main interests are pediatric diabetes mellitus and the physiology of fasting. She is the CHOP principal investigator for the National Institutes of Health multicenter Treatment Options for Diabetes Type 2 in Adolescents and Youth trial (TODAY), which will set the first treatment guidelines for the treatment of this condition in youth. Her independent clinical investigations include the natural history of insulin secretion in pediatric type 2 diabetes mellitus and the pediatric metabolic syndrome, as well as the endocrinologic effects of adolescent weight loss.
Dr. Stephen Kemp Stephen Kemp, MD, PhD, received his MD and PhD degrees from The University of Chicago and did his postgraduate training at Stanford University. He has been at the University of Arkansas for Medical Sciences and Arkansas Children’s Hospital since 1984 and was chief of the Section of Pediatric Endocrinology from 1987 to 2001. Dr. Kemp’s research interests have been in the field of growth and growth hormone therapy, and he is the author of numerous publications related to this topic. From 1992 to 2010, Dr. Kemp was an advisor to the National Cooperative Growth Study. He is past president of the Human Growth Foundation.
Dr. Stephen Lafranchi Stephen LaFranchi, MD, is professor of pediatrics at the Oregon Health & Science University. Dr. LaFranchi received his MD from the University of California, Los Angeles (UCLA), followed by both pediatric residency and pediatric endocrine fellowship training at UCLA (1969-1975). After completion of his training, he joined the faculty in Oregon, serving as chief of Pediatric Endocrinology from 1975 to 2001. He is the pediatric endocrine consultant to the Northwest Newborn Screening Program and was the primary author of the first American Academy of Pediatrics guidelines for management of congenital hypothyroidism.

Bradley S. Miller, MD, PhD, completed his MD and PhD in a combined program at the Medical University of South Carolina (1997). His doctoral thesis research focused on signal transduction of the insulinlike growth factor receptor. Dr. Miller completed his pediatric residency (2000) and pediatric endocrinology fellowship (2003) at the Mayo Clinic. He has been at the University of Minnesota since 2003 where he is associate professor in pediatric endocrinology and director of Growth Programs. Dr. Miller has an interest in the role of the growth hormone/insulinlike growth factor system in normal and abnormal growth in children. He is also interested in the growth and development of children following adversity including cancer and its therapies, fetal alcohol exposure, and international adoption. Dr. Miller has been an investigator in numerous clinical trials of therapy for children with growth and puberty disorders.

Dr. Jerry Olshan Jerrold S. Olshan, MD, received his undergraduate degree and medical degree from The University of Chicago and the Pritzker School of Medicine, respectively. He trained in pediatrics at Yale University and completed a fellowship in pediatric endocrinology and diabetes at the Children’s Hospital of Philadelphia and the University of Pennsylvania School of Medicine. He then established the division of pediatric endocrinology and diabetes at the Maine Medical Center in Portland, Maine, and more recently at the Barbara Bush Children’s Hospital at Maine Medical Center, and he is currently the director of the Division of Pediatric and Adolescent Endocrinology and Diabetes. He has won many awards for teaching both with medical students and pediatric residents and is currently an associate professor of pediatrics at Tufts University School of Medicine.
Dr. Constantine Stratakis Constantine A. Stratakis, MD, D(med)Sci,  received his MD and doctor of medical sciences degrees from the University of Athens; he was trained at Georgetown University Medical School, Washington, DC, where he finished a residency in pediatrics and fellowships in pediatric endocrinology, medical genetics, and clinical dysmorphology. Dr. Stratakis is board certified in pediatrics, pediatric endocrinology, and medical genetics; he was a faculty member of the Georgetown University Department of Pediatrics and the Fairfax Children’s Hospital until he joined the Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, as a unit chief in 1996. He continued there as a senior investigator and chief of the Genetics and Endocrinology Section. Since 2002, he has been the director of the Pediatric Endocrinology Training Fellowship and head of the Program on Developmental Endocrinology and Genetics. He is the author of more than 400 publications, has served as a reviewer for more than 100 journals, and is currently serving on the editorial boards of several journals, including acting as the deputy editor of the Journal of Clinical Endocrinology and Metabolism. Dr. Stratakis was the recipient of the 1999 Pharmacia-Endocrine Society Award for Excellence in Published Clinical Research and of National Institutes of Health Merit Awards and other honors, including the 2009 Ernst Oppenheimer Award of The Endocrine Society. As of July 1, 2009, he has been the acting scientific director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Dr. Stratakis is involved in Pediatric ESAP not in his capacity as a federal employee.

Dr. Stuart Weinzimer Stuart A. Weinzimer, MD, is associate professor of pediatrics at the Yale School of Medicine and the director of the Yale Pediatric Endocrinology Fellowship Program. He earned his bachelor’s degree in molecular biochemistry and biophysics at Yale and his MD degree at the Albert Einstein College of Medicine. He completed his pediatric residency and pediatric endocrinology fellowship training at the Children’s Hospital of Philadelphia and was on the faculty at the University of Pennsylvania before moving back to Yale in 2002 to focus his academic activities on the role of pumps, sensors, and other technologies in type 1 diabetes. He is the principal investigator of the Yale site in the National Institutes of Health–funded Diabetes Research in Children Network (DirecNet), and is the principal investigator for several National Institutes of Health– and Juvenile Diabetes Research Foundation–funded artificial pancreas projects.

Abbie Young

Abbie L. Young, MS, CGC, ELS(D), is a medical writer and editor. She received her MS degree in genetic counseling in 2002 from the University of Minnesota and is a board-certified genetic counselor. She earned her Certificate in Medical Writing and Editing in 2007 from The University of Chicago, and she became a board-certified Editor in the Life Sciences in 2008. Ms. Young specializes in manuscript editing, editing educational content for physicians, and developing patient education materials. Her previous work as a genetic counselor in the Molecular Genetics Laboratory at the Mayo Clinic and in the Newborn Screening Program at the Minnesota Department of Health has provided a broad foundation in medicine and public health.